NYSE / NASDAQ · SEC EDGAR

Equity research

Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.

Research preview · Quarterly financial statements · No price quotes · Not financial advice

2–3 year stock research →

7626Listed tickers in the SEC universe 4350Issuers with current reporting periods 1430Issuers with both EPS and ROE metrics 2026-11-06Fundamentals evaluated as of

Example screens

Period 1M3M6M1Y5YMAX
Drawing LineCandles
Reset filters

All selected filters are combined. Paste up to 100 tickers to intersect your own list with the results. A missing metric does not pass a numeric filter.

1376 companies match

Showing 451–500 of 1376 · page 10/28

Per page 2550100

Companies with a published price series: 1374 of 1376 · Daily EOD closes from the BibaMoney price store (splits reflected, cash dividends not) · 2026-11-06

ESAB NYSE

ESAB Corp

69.76 +39.52% MAX
Combined rank
26.3
EPS acceleration
-25.0 pp
ROE
6.8%
L NYSE

LOEWS CORP

111.32 +170.52% MAX
Combined rank
25.0
EPS acceleration
-53.8 pp
ROE
8.1%
RDVT NASDAQ

Red Violet, Inc.

80.00 +1211.48% MAX
Combined rank
22.4
EPS acceleration
-68.2 pp
ROE
7.7%
KN NYSE

Knowles Corp

37.53 +167.12% MAX
Combined rank
22.3
EPS acceleration
-119.4 pp
ROE
9.0%
WAT NYSE

WATERS CORP /DE/

462.72 +191.96% MAX
Combined rank
22.0
EPS acceleration
-13.4 pp
ROE
1.1%
BIIB NASDAQ

BIOGEN INC.

254.46 +5.23% MAX
Combined rank
21.2
EPS acceleration
-19.7 pp
ROE
1.8%
VVX NYSE

V2X, Inc.

80.37 +427.71% MAX
Combined rank
20.1
EPS acceleration
-124.3 pp
ROE
8.1%
INCY NASDAQ

INCYTE CORP

123.89 +31.39% MAX
Combined rank
15.4
EPS acceleration
-320.7 pp
ROE
7.1%
FIVN NASDAQ

Five9, Inc.

36.34 +131.76% MAX
Combined rank
14.1
EPS acceleration
-1700.0 pp
ROE
7.6%
MTW NYSE

MANITOWOC CO INC

23.03 +20.20% MAX
Combined rank
8.2
EPS acceleration
-760.7 pp
ROE
3.7%
Z NASDAQ

ZILLOW GROUP, INC.

30.96 -10.65% MAX
Combined rank
5.9
EPS acceleration
-833.3 pp
ROE
1.3%
IBTA NYSE

Ibotta, Inc.

48.62 -52.46% MAX
Combined rank
5.8
EPS acceleration
-237.5 pp
ROE
-6.7%
HLIT NASDAQ

HARMONIC INC.

10.23 +72.51% MAX
Combined rank
5.5
EPS acceleration
-206.7 pp
ROE
-13.1%
DCO NYSE

DUCOMMUN INC /DE/

160.28 +601.75% MAX
Combined rank
4.9
EPS acceleration
-555.2 pp
ROE
-3.1%
TRMB NASDAQ

TRIMBLE INC.

64.94 +127.38% MAX
Combined rank
4.9
EPS acceleration
-701.5 pp
ROE
-2.0%

How the lists overlap

EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.

The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.

Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.

What this data covers

Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.

The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.

Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.

Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.